Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.98 +0.83%   SPY: 135.51 +0.24%
Quote Spy KERX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Keryx Biopharmaceuticals (KERX)

@ 3:08 PM
Click the portfolio to add KERX:
Close [X]
+ Add KERX to Portfolio
  
  Last Trade: $3.31 -0.15 (-4.34%)
  Volume: 1,250,683 105% of avg daily volume
       
  Avg Volume: 1,208,347
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.25 - 3.50
  Open: 3.48
  Previous Close: 3.46
  52-wk Range: 2.27 - 5.55
  Market Cap: 245.0M
  P/E: -9.1
  Div Yield: $0.00 (0.00%)
Indexes
Cancer Stocks (-0.7%)
Spy KERX

? Pro holders
? Member holders
? Items submitted
Additional KERX resources



Customize Links
To see which Pros and tickerspy members own KERX Sign up now
Latest KERX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

What to watch at ASH 2010
SGEN  ARRY  AEZS  KERX  NVS  CYCC  YMI  
Linked by Chasing the Alpha - December 03, 05:05PM from (www.chasingthealpha.com)
The 52nd Annual Meeting of the American Society of Hematology (ASH) kicks off this weekend and with that in mind, we  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Keryx Kidney Drug Shows Encouraging Results
[CLDA]  KERX  
Linked by Forbes - November 30, 03:14PM from (www.forbes.com)
Biopharmaceutical firm announces positive signals from study assessing the efficacy of its Zerenex treatment.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Keryx Biopharmaceuticals ($KERX) to Hold Conference Call Tomorrow at 8:30 AM ET to Discuss Top-Line Results from Zerenex Phase 3 Short-Term Study
KERX  
Linked by Chasing the Alpha - November 29, 07:14PM from (www.chasingthealpha.com)
Sounds like tomorrow we will see what Zenerex is worth. Not currently holding any KERX, obviously I have a casual interest via AEZS and perifosine. Best of luck tomorrow.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Daily Review 6/8/2010
BSDM  CXM  AEZS  KERX  NNVC  [ABII]  
Linked by Chasing the Alpha - June 08, 11:34AM from (www.chasingthealpha.com)
Seriously, I am very concerned going forward. It is hard to know if we have hit another bottom and will rebound again. I  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioHealth Business Daily
BMY  [JAV]  CLDX  CELG  DCTH  VVUS  PCYC  ARQL  BPAX  KERX  APPY  [TLCR]  
Linked by 24/7 Wall St. - June 07, 01:22PM from (247wallst.com)
Today's edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ASCO - A Big Deal For Biotechs
ABT  BMY  MRK  ARIA  NKTR  ARQL  AEZS  KERX  VNDA  
Linked by Investopedia Stock Analysis - May 27, 09:04AM from (stocks.investopedia.com)
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ASCO abstracts already making headlines!
CLDX  EXEL  PCYC  ZIOP  AEZS  KERX  
Linked by Chasing the Alpha - May 20, 08:59PM from (www.chasingthealpha.com)
I am going to highlight these companies in more detail, but figured I would get the news out there. These company's abstracts  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Keryx Biopharmaceuticals "market outperform," target price raised
KERX  
Linked by newratings - May 12, 04:13PM from (www.newratings.com)
NEW YORK, May 12 (newratings.com) - Analysts at Rodman & Renshaw reiterate their "market outperform" rating  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Another Big Day For Biotechs As Cancer Stocks Surge
QLTI  [CEPH]  ARIA  SGEN  DNDN  KERX  ANX  
Linked by tickerspy Newswire - May 11, 01:29PM from (www.tickerspy.com)
The biotech sector heated up again on Tuesday as traders flocked to Adventrx Pharmaceuticals (ANX), Ariad Pharmaceuticals  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource